Kura Oncology (KURA) Shares Outstanding (2010 - 2026)

Kura Oncology (KURA) has 17 years of Shares Outstanding data on file, last reported at $88.8 million in Q1 2026.

• Shares Outstanding for Q1 2026 came in at $88.8 million, up 9.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $88.8 million (up 9.89% YoY), and the FY2025 annual result was $87.9 million, up 12.3% from the prior year.
• Shares Outstanding climbed to $88.8 million in Q1 2026 per KURA's latest filing, from $87.9 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $88.8 million in Q1 2026 and troughed at $66.6 million in Q1 2022.
• A 5-year average of $76.5 million and a median of $76.2 million in 2024 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding grew 0.56% in 2022, then climbed 13.58% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $68.3 million in 2022, then advanced by 8.84% to $74.4 million in 2023, then climbed by 5.22% to $78.2 million in 2024, then rose by 12.3% to $87.9 million in 2025, then grew by 1.03% to $88.8 million in 2026.
• Business Quant data shows KURA's Shares Outstanding at $88.8 million in Q1 2026, $87.9 million in Q4 2025, and $87.0 million in Q3 2025.